Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New potential oral cancer therapy developed in Korea

April 13, 2012

Novel PFK/FBPase inhibitors divulged by Kancera

April 13, 2012

U.S. university patents new histone demethylase inhibitors

April 13, 2012

Santaris Pharma identifies new candidate gene therapies for cancer

April 13, 2012

Wilex begins phase Ib/II study of WX-554

April 12, 2012

First-in-human data presented on hypomethylating anticancer agent

April 12, 2012

New orally bioavailable TTK inhibitor described

April 12, 2012

Novel c-Met inhibitors reported

April 12, 2012

Researchers at IRM patent novel Trk-A inhibitors

April 12, 2012

HSP 90 inhibitor enters phase I trial in multiple myeloma

April 11, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...